[
    "{\"step_by_step_thinking\": \"Dupilumab is a monoclonal antibody that is designed to inhibit overactive signaling of two key proteins, IL-4 and IL-13, which are believed to drive the underlying inflammation in asthma. Clinical trials have shown that Dupilumab can reduce severe asthma attacks and improve lung function, therefore it is considered effective for the treatment of asthma.\", \"answer_choice\": \"A\"}"
]